Rallis India Limited (RALLIS) Fair Value & Analysis
Basic Materials · IN · Market cap ₹44.2B
Fair value as of: Jul 3, 2026
From 26 valuation models · updated today
Share price −2.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹215.49 – ₹376.23 · fair‑value band ₹102.92 – ₹201.06 · the ₹228.14 price screens above the ₹160.85 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Rallis India Limited (RALLIS) currently trades at ₹228.14, while our model-based Fair Value estimate is ₹160.85 — implying the stock looks roughly 29.5% overvalued today. We read business quality at 56/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Rallis India Limited generated revenue of ₹29.0B at a net margin of 6.4%. Revenue grew 6.0% year over year. It earns a return on equity of 9.3%. Net debt stands at ₹221M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Rallis India Limited manufactures and markets crop care and seed products in India and internationally. It offers crop protection products, including insecticides, herbicides, fungicides, and bio pesticide; organic and micronutrient fertilizers, and plant growth nutrients; seeds, such as maize, watermelon, cauliflower, cabbage, bottle gourd, cucumber, bitter gourd, chilli, okra, tomato, millet, paddy, and cotton; and animal nutrition products. The company also provides household products, such as Termex, an insecticide for termite control; Sentry, a chemical composition; and Ralligel plus, a chemical for cockroach control. In addition, it offers contract manufacturing services for crop protection chemicals, specialty chemicals, polymers, and intermediates. Further, the company sells soil and plant health solutions, including bio-fertilizers, bio-stimulants, micro-nutrients, organic fertilizers, water soluble fertilizers, and bio-pesticides. It offers its products through a network …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Rallis India Limited reported revenue of ₹29.0B in FY2026 versus ₹25.9B in FY2022, a compound +2.8%/yr. Reported net income was ₹1.8B in FY2026, compounding +2.9%/yr from FY2022.
Is RALLIS fairly valued? → Check now
Similar stocks
6 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Corteva, Inc CTVA | $78.86 | $41.93 | -47% |
| Nutrien Ltd NTR | $68.50 | $52.75 | -23% |
| Qinghai Salt Lake Industry Co 000792 | ¥29.03 | ¥21.15 | -27% |
| CF Industries Holdings C1FI34 | R$627.77 | R$947.15 | +51% |
| Yara International ASA YAR | kr 433.40 | kr 67.25 | -84% |
| ICL Group ICL | $5.07 | $2.88 | -43% |
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is Rallis India Limited (RALLIS) undervalued?
What is the fair value of RALLIS?
What is the quality score of RALLIS?
What is the revenue of Rallis India Limited (RALLIS)?
What is the net profit margin of RALLIS?
Does Rallis India Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.